These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 24273094)

  • 1. Lead evaluation of tetrahydroquinolines as nonsteroidal selective androgen receptor modulators for the treatment of osteoporosis.
    Nagata N; Furuya K; Oguro N; Nishiyama D; Kawai K; Yamamoto N; Ohyabu Y; Satsukawa M; Miyakawa M
    ChemMedChem; 2014 Jan; 9(1):197-206. PubMed ID: 24273094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtle structural changes in tetrahydroquinolines, a new class of nonsteroidal selective androgen receptor modulators, induce different functions.
    Nagata N; Kawai K; Nakanishi I
    J Chem Inf Model; 2012 Aug; 52(8):2257-64. PubMed ID: 22794275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-androgenic effects of S-40542, a novel non-steroidal selective androgen receptor modulator (SARM) for the treatment of benign prostatic hyperplasia.
    Nejishima H; Yamamoto N; Suzuki M; Furuya K; Nagata N; Yamada S
    Prostate; 2012 Oct; 72(14):1580-7. PubMed ID: 22430536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrahydroquinolines as a novel series of nonsteroidal selective androgen receptor modulators: structural requirements for better physicochemical and biological properties.
    Nagata N; Miyakawa M; Amano S; Furuya K; Yamamoto N; Nejishima H; Inoguchi K
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6310-3. PubMed ID: 21944856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of tricyclic tetrahydroquinolines as a new series of nonsteroidal selective androgen receptor modulators (SARMs).
    Nagata N; Miyakawa M; Amano S; Furuya K; Yamamoto N; Inoguchi K
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1744-7. PubMed ID: 21349712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of B-ring substitution pattern on binding mode of propionamide selective androgen receptor modulators.
    Bohl CE; Wu Z; Chen J; Mohler ML; Yang J; Hwang DJ; Mustafa S; Miller DD; Bell CE; Dalton JT
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5567-70. PubMed ID: 18805694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological activity of a novel series of nonsteroidal, peripherally selective androgen receptor antagonists derived from 1,2-dihydropyridono[5,6-g]quinolines.
    Hamann LG; Higuchi RI; Zhi L; Edwards JP; Wang XN; Marschke KB; Kong JW; Farmer LJ; Jones TK
    J Med Chem; 1998 Feb; 41(4):623-39. PubMed ID: 9484511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substituted 6-(1-pyrrolidine)quinolin-2(1H)-ones as novel selective androgen receptor modulators.
    Martinborough E; Shen Y; Oeveren Av; Long YO; Lau TL; Marschke KB; Chang WY; López FJ; Vajda EG; Rix PJ; Viveros OH; Negro-Vilar A; Zhi L
    J Med Chem; 2007 Oct; 50(21):5049-52. PubMed ID: 17887661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure, docking study and structure-activity relationship of carborane-containing androgen receptor antagonist 3-(12-hydroxymethyl-1,12-dicarba-closo-dodecaboran-1-yl)benzonitrile.
    Ohta K; Goto T; Fujii S; Kawahata M; Oda A; Ohta S; Yamaguchi K; Hirono S; Endo Y
    Bioorg Med Chem; 2011 Jun; 19(11):3540-8. PubMed ID: 21536446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone anabolic effects of S-40503, a novel nonsteroidal selective androgen receptor modulator (SARM), in rat models of osteoporosis.
    Hanada K; Furuya K; Yamamoto N; Nejishima H; Ichikawa K; Nakamura T; Miyakawa M; Amano S; Sumita Y; Oguro N
    Biol Pharm Bull; 2003 Nov; 26(11):1563-9. PubMed ID: 14600402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of potent and muscle selective androgen receptor modulators through scaffold modifications.
    Li JJ; Sutton JC; Nirschl A; Zou Y; Wang H; Sun C; Pi Z; Johnson R; Krystek SR; Seethala R; Golla R; Sleph PG; Beehler BC; Grover GJ; Fura A; Vyas VP; Li CY; Gougoutas JZ; Galella MA; Zahler R; Ostrowski J; Hamann LG
    J Med Chem; 2007 Jun; 50(13):3015-25. PubMed ID: 17552509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of 6-N,N-bis(2,2,2-trifluoroethyl)amino- 4-trifluoromethylquinolin-2(1H)-one as a novel selective androgen receptor modulator.
    van Oeveren A; Motamedi M; Mani NS; Marschke KB; López FJ; Schrader WT; Negro-Vilar A; Zhi L
    J Med Chem; 2006 Oct; 49(21):6143-6. PubMed ID: 17034117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel selective androgen receptor modulators: SAR studies on 6-bisalkylamino-2-quinolinones.
    van Oeveren A; Motamedi M; Martinborough E; Zhao S; Shen Y; West S; Chang W; Kallel A; Marschke KB; López FJ; Negro-Vilar A; Zhi L
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1527-31. PubMed ID: 17267219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective androgen receptor modulators for frailty and osteoporosis.
    Kilbourne EJ; Moore WJ; Freedman LP; Nagpal S
    Curr Opin Investig Drugs; 2007 Oct; 8(10):821-9. PubMed ID: 17907058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo structure-activity relationships of novel androgen receptor ligands with multiple substituents in the B-ring.
    Chen J; Hwang DJ; Chung K; Bohl CE; Fisher SJ; Miller DD; Dalton JT
    Endocrinology; 2005 Dec; 146(12):5444-54. PubMed ID: 16166218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and in vivo SAR of a novel series of pyrazolines as potent selective androgen receptor modulators.
    Zhang X; Li X; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z
    J Med Chem; 2007 Aug; 50(16):3857-69. PubMed ID: 17636947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of nonsteroidal cycloalkane[d]isoxazole-containing androgen receptor modulators.
    Poutiainen PK; Oravilahti T; Peräkylä M; Palvimo JJ; Ihalainen JA; Laatikainen R; Pulkkinen JT
    J Med Chem; 2012 Jul; 55(14):6316-27. PubMed ID: 22746350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The systematic structure-activity relationship to predict how flavones bind to human androgen receptor for their antagonistic activity.
    Tamura H; Yoshioka M; Hasegawa M; Hosoda A; Matsugi M; Akamatsu M
    Bioorg Med Chem; 2013 Jun; 21(11):2968-74. PubMed ID: 23611768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and Biological Evaluation of Cyclopentaquinoline Derivatives as Nonsteroidal Glucocorticoid Receptor Antagonists.
    Eda M; Kuroda T; Kaneko S; Aoki Y; Yamashita M; Okumura C; Ikeda Y; Ohbora T; Sakaue M; Koyama N; Aritomo K
    J Med Chem; 2015 Jun; 58(12):4918-26. PubMed ID: 25978072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of nonsteroidal glucocorticoid receptor ligands based on 6-indole-1,2,3,4-tetrahydroquinolines.
    Roach SL; Higuchi RI; Adams ME; Liu Y; Karanewsky DS; Marschke KB; Mais DE; Miner JN; Zhi L
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3504-8. PubMed ID: 18513967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.